Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT-DCB: 1-Month vs 6-Month DAPT After DCB-Only PCI
NCT07879430Not yet recruiting
- Sponsor
- Ulsan University Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2028
01
Overview
Randomised, open-label trial of aspirin in coronary artery disease (CAD) (2 arms), sponsored by Ulsan University Hospital. Primary endpoint: Net Adverse Clinical Events at 12 months. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07879430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07879430.